Matthew L Rohlfing1, Ashley C Mays2, Scott Isom3, Joshua D Waltonen4. 1. Department of Otolaryngology, Boston Medical Center, Boston, Massachusetts. 2. Department of Otolaryngology, MD Anderson Cancer Center, Houston, Texas. 3. Department of Biostatistical Sciences, Comprehensive Cancer Center, Wake Forest Baptist Health, Winston-Salem, North Carolina, USA. 4. Department of Otolaryngology, Wake Forest Baptist Health, Winston-Salem, North Carolina, USA.
Abstract
OBJECTIVE: Explore relationship between insurance status and survival, determine outcomes that vary based on insurance status, and identify potential areas of intervention. STUDY DESIGN: Retrospective cohort analysis of patients who underwent resection of an upper aerodigestive tract malignancy at a single tertiary care hospital during a 5-year period. METHODS: Patients were categorized into four groups by insurance status: Medicaid or uninsured, Medicare and under 65 years of age, Medicare and 65 years or older, and private insurance. Data were collected from the medical record and analyzed with respect to survival and other outcomes. RESULTS: The final cohort consisted of 860 patients. Survival analysis demonstrated a hazard ratio of 2.1 (95% confidence interval [CI], 1.5-3.0) for the Medicaid/uninsured group when compared to the private insurance group. When adjusted for other variables, mortality was still different across insurance groups (P = 0.002). The following also were different across insurance groups: tumor stage (P < 0.001), American Society of Anesthesiologists score (P < 0.001), length of stay (P < 0.001), and complications (P = 0.021). The Medicaid/uninsured group was most likely to have a complication (odds ratio [OR] = 2.10, 95% CI 1.24-3.56, P = 0.006). CONCLUSION: Medicaid/uninsured patients present with more advanced tumors and have poorer survival than privately insured patients. Insurance status is predictive of tumor stage, comorbidity burden, length of stay, and complications. Specifically, the Medicaid/uninsured group had high rates of tobacco use and alcohol abuse, advanced stage tumors, and postoperative complications. Because alcohol abuse and advanced stage also were predictors of poor survival, they may contribute to the survival disparity for socially disadvantaged patients. LEVEL OF EVIDENCE: 4. Laryngoscope, 127:2784-2789, 2017.
OBJECTIVE: Explore relationship between insurance status and survival, determine outcomes that vary based on insurance status, and identify potential areas of intervention. STUDY DESIGN: Retrospective cohort analysis of patients who underwent resection of an upper aerodigestive tract malignancy at a single tertiary care hospital during a 5-year period. METHODS:Patients were categorized into four groups by insurance status: Medicaid or uninsured, Medicare and under 65 years of age, Medicare and 65 years or older, and private insurance. Data were collected from the medical record and analyzed with respect to survival and other outcomes. RESULTS: The final cohort consisted of 860 patients. Survival analysis demonstrated a hazard ratio of 2.1 (95% confidence interval [CI], 1.5-3.0) for the Medicaid/uninsured group when compared to the private insurance group. When adjusted for other variables, mortality was still different across insurance groups (P = 0.002). The following also were different across insurance groups: tumor stage (P < 0.001), American Society of Anesthesiologists score (P < 0.001), length of stay (P < 0.001), and complications (P = 0.021). The Medicaid/uninsured group was most likely to have a complication (odds ratio [OR] = 2.10, 95% CI 1.24-3.56, P = 0.006). CONCLUSION: Medicaid/uninsured patients present with more advanced tumors and have poorer survival than privately insured patients. Insurance status is predictive of tumor stage, comorbidity burden, length of stay, and complications. Specifically, the Medicaid/uninsured group had high rates of tobacco use and alcohol abuse, advanced stage tumors, and postoperative complications. Because alcohol abuse and advanced stage also were predictors of poor survival, they may contribute to the survival disparity for socially disadvantaged patients. LEVEL OF EVIDENCE: 4. Laryngoscope, 127:2784-2789, 2017.
Authors: R G Roetzheim; N Pal; C Tennant; L Voti; J Z Ayanian; A Schwabe; J P Krischer Journal: J Natl Cancer Inst Date: 1999-08-18 Impact factor: 13.506
Authors: Daniel G Deschler; Jeremy D Richmon; Samir S Khariwala; Robert L Ferris; Marilene B Wang Journal: Otolaryngol Head Neck Surg Date: 2014-06-12 Impact factor: 3.497
Authors: Joseph Kwok; Scott M Langevin; Athanassios Argiris; Jennifer R Grandis; William E Gooding; Emanuela Taioli Journal: Cancer Date: 2010-01-15 Impact factor: 6.860
Authors: Jason S Radowsky; Leah B Helou; Robin S Howard; Nancy P Solomon; Alexander Stojadinovic Journal: Surgery Date: 2012-08-03 Impact factor: 3.982
Authors: Felix V Chen; Tulay Koru-Sengul; Feng Miao; Joshua S Jue; Mahmoud Alameddine; Devina J Dave; Sanoj Punnen; Dipen J Parekh; Chad R Ritch; Mark L Gonzalgo Journal: Urol Oncol Date: 2019-08-14 Impact factor: 3.498
Authors: Eric Adjei Boakye; Nosayaba Osazuwa-Peters; Betty Chen; Miao Cai; Betelihem B Tobo; Sai D Challapalli; Paula Buchanan; Jay F Piccirillo Journal: JAMA Otolaryngol Head Neck Surg Date: 2020-05-01 Impact factor: 6.223
Authors: Eric J Charles; J Hunter Mehaffey; Robert B Hawkins; Clifford E Fonner; Leora T Yarboro; Mohammed A Quader; Andy C Kiser; Jeffrey B Rich; Alan M Speir; Irving L Kron; Margaret C Tracci; Gorav Ailawadi Journal: Ann Thorac Surg Date: 2019-01-22 Impact factor: 4.330
Authors: Richard B Cannon; Hailey M Shepherd; Hilary McCrary; Patrick S Carpenter; Luke O Buchmann; Jason P Hunt; Jeffrey J Houlton; Marcus M Monroe Journal: JAMA Otolaryngol Head Neck Surg Date: 2018-11-01 Impact factor: 6.223
Authors: Yoon H Lee; Andrew X Chen; Varshini Varadaraj; Gloria H Hong; Yimin Chen; David S Friedman; Joshua D Stein; Nicholas Kourgialis; Joshua R Ehrlich Journal: JAMA Ophthalmol Date: 2018-06-01 Impact factor: 7.389
Authors: Susanna Hilda Hutajulu; Daniel Howdon; Kartika Widayati Taroeno-Hariadi; Mardiah Suci Hardianti; Ibnu Purwanto; Sagung Rai Indrasari; Camelia Herdini; Bambang Hariwiyanto; Ahmad Ghozali; Henry Kusumo; Wigati Dhamiyati; Sri Retna Dwidanarti; I Bing Tan; Johan Kurnianda; Matthew John Allsop Journal: PLoS One Date: 2021-02-12 Impact factor: 3.240